1. Home
  2. CRGO vs PYPD Comparison

CRGO vs PYPD Comparison

Compare CRGO & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freightos Limited Ordinary shares

CRGO

Freightos Limited Ordinary shares

HOLD

Current Price

$1.36

Market Cap

88.4M

Sector

Finance

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.57

Market Cap

85.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRGO
PYPD
Founded
2012
2008
Country
Spain
Israel
Employees
382
N/A
Industry
Blank Checks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.4M
85.1M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
CRGO
PYPD
Price
$1.36
$4.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$2.40
$12.25
AVG Volume (30 Days)
84.5K
146.9K
Earning Date
05-26-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.61
N/A
Revenue Next Year
$16.85
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$3.06
52 Week High
$4.24
$5.21

Technical Indicators

Market Signals
Indicator
CRGO
PYPD
Relative Strength Index (RSI) 26.05 45.83
Support Level $1.17 $4.18
Resistance Level $1.44 $4.56
Average True Range (ATR) 0.09 0.30
MACD -0.03 -0.00
Stochastic Oscillator 0.00 17.50

Price Performance

Historical Comparison
CRGO
PYPD

About CRGO Freightos Limited Ordinary shares

Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters, thousands of forwarders, and dozens of airlines and ocean carriers. The company operates in two segments: the Platform segment and the Solutions segment. The majority of the revenue is derived from the Solutions segment, which provides software tools and data to help industry participants automate their pricing, sales, and procurement processes. Geographically, it generates the maximum revenue from Europe, and the rest from the United States, Hong Kong and Others.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: